CY1114366T1 - Συνθεσεις που περιεχουν αποαικoυορiνη και μεθοδοι χρησης τους - Google Patents
Συνθεσεις που περιεχουν αποαικoυορiνη και μεθοδοι χρησης τουςInfo
- Publication number
- CY1114366T1 CY1114366T1 CY20131100128T CY131100128T CY1114366T1 CY 1114366 T1 CY1114366 T1 CY 1114366T1 CY 20131100128 T CY20131100128 T CY 20131100128T CY 131100128 T CY131100128 T CY 131100128T CY 1114366 T1 CY1114366 T1 CY 1114366T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methods
- compositions containing
- quality
- containing diagnostic
- diagnostic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Παρέχονται από την παρούσα εφεύρεση συνθέσεις που περιέχουν αποαικουορίνη και μέθοδοι για τη χρήση τους στην αντιμετώπιση των συμπτωμάτων και των διαταραχών σχετικών με ελλείψεις στο ισοζύγιο ασβεστίου που συνδέονται με, παραδείγματος χάριν, την ποιότητα ύπνου, την ποιότητα ενέργειας, την ποιότητα διάθεσης, την ποιότητα μνήμης ή τον πόνο.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3544308P | 2008-03-11 | 2008-03-11 | |
| EP09720761A EP2262525B1 (en) | 2008-03-11 | 2009-03-11 | Apoaequorin-containing compositions and methods of using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1114366T1 true CY1114366T1 (el) | 2016-08-31 |
Family
ID=40627496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20131100128T CY1114366T1 (el) | 2008-03-11 | 2013-02-13 | Συνθεσεις που περιεχουν αποαικoυορiνη και μεθοδοι χρησης τους |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8796213B2 (el) |
| EP (1) | EP2262525B1 (el) |
| JP (1) | JP5508294B2 (el) |
| KR (1) | KR101643662B1 (el) |
| CN (2) | CN106692945A (el) |
| AU (1) | AU2009223010B2 (el) |
| BR (1) | BRPI0909435A2 (el) |
| CA (1) | CA2717322C (el) |
| CY (1) | CY1114366T1 (el) |
| DK (1) | DK2262525T3 (el) |
| ES (1) | ES2401754T3 (el) |
| HR (1) | HRP20130205T1 (el) |
| IL (1) | IL207827A (el) |
| MX (1) | MX2010009753A (el) |
| NZ (1) | NZ588437A (el) |
| PL (1) | PL2262525T3 (el) |
| PT (1) | PT2262525E (el) |
| SI (1) | SI2262525T1 (el) |
| WO (1) | WO2009114597A1 (el) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2780027T (lt) * | 2011-11-15 | 2017-10-25 | Quincy Bioscience Llc | Apoekvorinas, skirtas sumažinti neuronų pažeidimą dėl išemijos |
| TR201818988T4 (tr) | 2012-09-27 | 2019-01-21 | Quincy Bioscience Llc | Multipl skleroz semptomlarını hafifletmeye yönelik apoaequorin içeren bileşimlere dayalı yöntemler. |
| MA40959A (fr) * | 2014-11-11 | 2017-09-19 | Quincy Bioscience Llc | Compositions contenant de l'apoaéquorine et leurs procédés d'utilisation pour traiter l'inflammation neuronale |
| EP3515212B1 (en) * | 2016-09-23 | 2024-07-24 | Quincy Bioscience LLC | Apoaequorin and vitamin d-containing compositions and methods of using same |
| US12070044B2 (en) | 2019-02-22 | 2024-08-27 | Aquero Canada Ltd. | Fortified milk compositions and their processes of preparation |
| EP4110312A1 (en) * | 2020-02-24 | 2023-01-04 | Quincy Bioscience, LLC | Apoaequorin and curcumin containing compositions and methods |
| EP4199901A1 (en) * | 2020-08-20 | 2023-06-28 | Quincy Bioscience, LLC | Effervescent formulation containing apoaequorin |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6447379A (en) * | 1987-08-19 | 1989-02-21 | Chisso Corp | Preparation of calcium-dependent oxygenation enzyme |
| US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
| CN1324045C (zh) | 2004-09-22 | 2007-07-04 | 中国科学院海洋研究所 | 从水母中分离的具有抗氧化活性的蛋白及其应用 |
-
2009
- 2009-03-11 AU AU2009223010A patent/AU2009223010B2/en active Active
- 2009-03-11 ES ES09720761T patent/ES2401754T3/es active Active
- 2009-03-11 JP JP2010550832A patent/JP5508294B2/ja active Active
- 2009-03-11 MX MX2010009753A patent/MX2010009753A/es active IP Right Grant
- 2009-03-11 PL PL09720761T patent/PL2262525T3/pl unknown
- 2009-03-11 SI SI200930489T patent/SI2262525T1/sl unknown
- 2009-03-11 CA CA2717322A patent/CA2717322C/en active Active
- 2009-03-11 KR KR1020107022674A patent/KR101643662B1/ko active IP Right Grant
- 2009-03-11 CN CN201710007032.8A patent/CN106692945A/zh active Pending
- 2009-03-11 NZ NZ588437A patent/NZ588437A/en unknown
- 2009-03-11 CN CN200980108891XA patent/CN101969979A/zh active Pending
- 2009-03-11 US US12/672,463 patent/US8796213B2/en active Active
- 2009-03-11 EP EP09720761A patent/EP2262525B1/en active Active
- 2009-03-11 DK DK09720761.7T patent/DK2262525T3/da active
- 2009-03-11 PT PT97207617T patent/PT2262525E/pt unknown
- 2009-03-11 BR BRPI0909435A patent/BRPI0909435A2/pt not_active Application Discontinuation
- 2009-03-11 WO PCT/US2009/036767 patent/WO2009114597A1/en active Application Filing
-
2010
- 2010-08-26 IL IL207827A patent/IL207827A/en active IP Right Grant
-
2013
- 2013-02-13 CY CY20131100128T patent/CY1114366T1/el unknown
- 2013-03-08 HR HRP20130205AT patent/HRP20130205T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009223010A1 (en) | 2009-09-17 |
| SI2262525T1 (sl) | 2013-03-29 |
| KR101643662B1 (ko) | 2016-07-29 |
| PL2262525T3 (pl) | 2013-04-30 |
| IL207827A (en) | 2013-08-29 |
| AU2009223010B2 (en) | 2014-01-09 |
| IL207827A0 (en) | 2010-12-30 |
| US8796213B2 (en) | 2014-08-05 |
| HRP20130205T1 (hr) | 2013-04-30 |
| BRPI0909435A2 (pt) | 2017-06-13 |
| WO2009114597A1 (en) | 2009-09-17 |
| CN106692945A (zh) | 2017-05-24 |
| US20110124562A1 (en) | 2011-05-26 |
| JP5508294B2 (ja) | 2014-05-28 |
| DK2262525T3 (da) | 2013-02-11 |
| KR20100136494A (ko) | 2010-12-28 |
| CA2717322A1 (en) | 2009-09-17 |
| CN101969979A (zh) | 2011-02-09 |
| ES2401754T3 (es) | 2013-04-24 |
| NZ588437A (en) | 2012-07-27 |
| MX2010009753A (es) | 2010-09-30 |
| CA2717322C (en) | 2017-07-11 |
| PT2262525E (pt) | 2013-01-28 |
| EP2262525A1 (en) | 2010-12-22 |
| EP2262525B1 (en) | 2012-12-26 |
| JP2011513496A (ja) | 2011-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121327T1 (el) | Τροποποιημενα αντισωματα anti-il-23p19 | |
| CY1122425T1 (el) | 3-[4-(7η-πυρρολο[2,3-d]πυριμιδιν-4-υλο)-1η-πυραζολ-1-υλ]οκτανο-ή επτανονιτριλιο ως αναστολεις jak | |
| CY1114366T1 (el) | Συνθεσεις που περιεχουν αποαικoυορiνη και μεθοδοι χρησης τους | |
| CY1120337T1 (el) | Θειοοξικες ενωσεις, συνθεσεις και μεθοδοι χρησης | |
| CY1119766T1 (el) | Νεοι ρυθμιστες κινασης βενζοπυρανιου | |
| CY1120154T1 (el) | Παραγωγα πιπεριδιν-4-υλ αζετιδινης ως αναστολεις jak1 | |
| CY1119123T1 (el) | Δις-αρυλοσυζευγμενες αρυλοτριαζολονες και η χρηση τους | |
| CY1116064T1 (el) | Συστασεις αναστολεα ddp iv | |
| CY1117743T1 (el) | Διυποκατεστημενα οκταϋδροπυρρολο [3,4-c]πυρρολια ως ρυθμιστες υποδοχεα ορεξινης | |
| CY1118680T1 (el) | Φαρμακευτικη συνθεση | |
| CY1114872T1 (el) | Συνθεσεις και μεθοδοι χρησης αντισωματων εναντι της σκληροστεϊνης | |
| CY1114952T1 (el) | Ενεργοποιητες θειενο[2,3-b]πυριδινοδιονης της αμρκ και θεραπευτικες χρησεις αυτων | |
| CY1117678T1 (el) | Ενωσεις αναστολεων μεταλλοενζυμου | |
| CY1112813T1 (el) | 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων | |
| CY1111123T1 (el) | Μεθοδοι χρησης υποδοχεα gpr119 για να πιστοποιουνται ενωσεις χρησιμες για αυξηση οστικης μαζας σε ενα ατομο | |
| CY1115350T1 (el) | Χρησεις αναστολεων της dpp iv | |
| CY1113665T1 (el) | Θετικοι αλλοστερικοι ρυθμιστες του υποδοχεα μ1 με αρυλομεθυλο βενζοκιναζολινονη | |
| CY1117654T1 (el) | Πολυαιθυλενογλυκολιωμενη απελινη και χρησεις αυτης | |
| CY1113963T1 (el) | Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ανταγωνιστες ακτιβινης-actriia και χρηση αυτων στην προληψη η' θεραπευτικη αγωγη πολλαπλου μυελωματος | |
| CY1119509T1 (el) | Συνθεσεις και μεθοδοι για ρυθμιστες αποπτωσης | |
| CY1119800T1 (el) | Συνδυασμοι υποδοχεα της 5-ητ4 και αναστολεων ακετυλοχολινεστερασης για τη θεραπεια γνωστικων διαταραχων | |
| CY1112724T1 (el) | Παραγωγα ανθρακικης κουινουκλιδινης και ιατρικη συνθεση αυτων | |
| EA201170252A1 (ru) | Амидофеноксиндазолы в качестве ингибиторов c-мет | |
| CY1114960T1 (el) | Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου | |
| CY1115437T1 (el) | Υδροξυμεθυλοκυκλοεξυλαμινες |